Table 4 Antimicrobial susceptibility rates of the isolated CLABSI organisms
Susceptibility n (%) | |||
|---|---|---|---|
Organisms | Agents | n | (%) |
Gram positive pathogens (60) | Beta-lactam | ||
Oxacillin | 17 | 28.3% | |
Cefazolin | 16 | 26.7% | |
Ceftriaxone | 16 | 26.7% | |
Meropenem | 17 | 28.3% | |
Vancomycin | 59 | 98.3% | |
Linezolid | 60 | 100.0% | |
Rifampicin | 49 | 81.7% | |
Trimethoprim-sulfamethoxazole | 30 | 50.0% | |
Gram negative pathogens (144) | B-Lactams | ||
Ceftriaxone | 70 | 48.6% | |
Ceftazidime | 98 | 68.1% | |
Cefepime | 98 | 68.1% | |
Piperacillin-tazobactam | 89 | 61.8% | |
Meropenem | 102 | 70.8% | |
Ciprofloxacin | 41 | 28.5% | |
Trimethoprim-sulfamethoxazole | 73 | 50.7% | |
Aminoglycosides | 92 | 63.9% | |